Showing 4,421 - 4,440 results of 60,155 for search '(( 5 ((we decrease) OR (nn decrease)) ) OR ( 50 ((teer decrease) OR (a decrease)) ))', query time: 1.14s Refine Results
  1. 4421
  2. 4422
  3. 4423
  4. 4424

    Emerging Disinfection Byproduct 2,6-Dichlorobenzoquinone-Induced Cardiovascular Developmental Toxicity of Embryonic Zebrafish and Larvae: Imaging and Transcriptome Analysis by Xue Yang (144876)

    Published 2022
    “…Fluorescent images of transgenic zebrafish strains with fluorescently labeled heart and blood vessels show that DCBQ exposure resulted in deformed atrium–ventricle looping, degenerated abdomen and trunk vessels, pericardial edema, and decreased blood flow. Furthermore, the expression of the marker gene <i>myl7</i> (essential for the differentiation and motility of cardiomyocytes) was inhibited in a dose-dependent manner by DCBQ exposure. …”
  5. 4425

    Beverage Containing Dispersible Yeast β-Glucan Decreases Cold/Flu Symptomatic Days After Intense Exercise: A Randomized Controlled Trial by Eunice Mah (5918042)

    Published 2018
    “…<p>In this double-blind, randomized, placebo-controlled parallel study, we examined the effect of dairy-based beverages (250 mL/day) containing 250 mg of dispersible baker’s yeast β-glucan (Wellmune) compared to a macronutrient- and calorie-matched control on upper respiratory tract infection (URTI) in marathon runners. …”
  6. 4426
  7. 4427
  8. 4428
  9. 4429

    SPL treatment decreases diabetes-induced decrement in protein expression of cldn-5 in glomeruli (GL) and cldn-2 and occldn in proximal tubules (PT). by Eduardo Molina-Jijón (4020464)

    Published 2017
    “…<p>SPL prevents diabetes-induced decrease of cldn-5 protein expression (A and B) in GL, and mRNA (F) and protein expression of cldn-2 (A and C), and protein expression of occldn (A and D) in PT (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0177362#pone.0177362.s002" target="_blank">S2 Fig</a>). …”
  10. 4430
  11. 4431
  12. 4432
  13. 4433

    Simultaneous ablation of Syt1 and Syt7 decreases the RRP size at inhibitory synapses: Rescue by WT but not mutant Syt1 or Syt7. by Taulant Bacaj (803415)

    Published 2015
    “…Recordings were performed in the presence of 1 μM tetrodotoxin, 20 μM CNQX, and 50 μM AP5 to isolate inhibitory currents. <b>B.</b> Simultaneous ablation of Syt1 and Syt7 decreases the RRP size of inhibitory synapses in a manner that is rescued by WT Syt7 (Syt1<sup>WT</sup>) but not Syt7 with mutations in the top C2 domain sequences containing the Syt7 Ca<sup>2+</sup> binding sites (Syt7<sup>C2A</sup>*<sup>B</sup>*). …”
  14. 4434
  15. 4435

    Decreased total iron binding capacity upon intensive care unit admission predicts red blood cell transfusion in critically ill patients by Taro Imaeda (6256550)

    Published 2019
    “…<div><p>Introduction</p><p>Red blood cell (RBC) transfusion is associated with poor clinical outcome in critically ill patients. We investigated the predictive value of biomarkers on intensive care units (ICU) admission for RBC transfusion within 28 days.…”
  16. 4436

    Reduced ezrin or p130Cas expression in ES2 cells resulted in decreased cell branching capacity on Matrigel and reduced invasion ability. by Vered Horwitz (3117960)

    Published 2016
    “…ES2 cells with reduced ezrin expression (ES2-T2) showed 50% decrease in invasion ability compared the cells transfected with no plasmid (ES2-C1) and non-transfected cells (ES2-C2) (*, p<0.01). …”
  17. 4437

    Proportions of activated (CD38+HLA-DR+) and cycling (Ki67+) CD4+ and CD8+ T cells decreased following initiation of ART. by Nicholas T. Funderburg (379171)

    Published 2013
    “…<div><p>Among both A) CD4+ and B) CD8+ T cell populations, initiation of raltegravir plus emtricitabine/tenofovir resulted in a significant decrease from baseline in the proportion of activated cells by 2 days and 7 days (p= 0.05 and 0.015, respectively). …”
  18. 4438

    Table_5_Effect of high-dose Spirulina supplementation on hospitalized adults with COVID-19: a randomized controlled trial.docx by Mohammad Reza Aghasadeghi (9524778)

    Published 2024
    “…This study aimed to evaluate the efficacy and safety of high-dose Spirulina platensis for SARS-CoV-2 infection.</p>Study Design<p>We conducted a randomized, controlled, open-label trial involving 189 patients with COVID-19 who were randomly assigned in a 1:1 ratio to an experimental group that received 15.2g of Spirulina supplement plus standard treatment (44 non-intensive care unit (non-ICU) and 47 ICU), or to a control group that received standard treatment alone (46 non-ICU and 52 ICU). …”
  19. 4439
  20. 4440